Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 19, 2023

BUY
$25.3 - $39.67 $25,704 - $40,304
1,016 Added 1.75%
58,965 $1.64 Million
Q1 2023

May 12, 2023

BUY
$30.21 - $48.1 $315,362 - $502,115
10,439 Added 21.97%
57,949 $1.93 Million
Q4 2022

Feb 10, 2023

SELL
$22.28 - $38.71 $923,661 - $1.6 Million
-41,457 Reduced 46.6%
47,510 $1.46 Million
Q3 2022

Nov 03, 2022

BUY
$34.2 - $51.69 $396,583 - $599,397
11,596 Added 14.99%
88,967 $3.04 Million
Q2 2022

Aug 09, 2022

SELL
$23.14 - $49.68 $453,544 - $973,728
-19,600 Reduced 20.21%
77,371 $2.68 Million
Q1 2022

May 09, 2022

BUY
$27.77 - $64.4 $1.03 Million - $2.39 Million
37,140 Added 62.07%
96,971 $4.27 Million
Q4 2021

Feb 10, 2022

SELL
$54.9 - $105.21 $1.78 Million - $3.41 Million
-32,403 Reduced 35.13%
59,831 $3.76 Million
Q3 2021

Nov 09, 2021

BUY
$105.0 - $178.37 $2.5 Million - $4.25 Million
23,823 Added 34.82%
92,234 $9.72 Million
Q2 2021

Aug 05, 2021

BUY
$125.11 - $180.0 $983,114 - $1.41 Million
7,858 Added 12.98%
68,411 $12.1 Million
Q1 2021

May 11, 2021

BUY
$126.27 - $191.71 $7.65 Million - $11.6 Million
60,553 New
60,553 $8.08 Million
Q4 2020

Feb 11, 2021

SELL
$81.94 - $135.34 $892,572 - $1.47 Million
-10,893 Closed
0 $0
Q3 2020

Nov 02, 2020

BUY
$73.3 - $89.48 $221,805 - $270,766
3,026 Added 38.46%
10,893 $906,000
Q2 2020

Aug 11, 2020

SELL
$48.82 - $82.53 $391,292 - $661,477
-8,015 Reduced 50.47%
7,867 $646,000
Q1 2020

May 05, 2020

BUY
$39.1 - $62.9 $620,986 - $998,977
15,882 New
15,882 $818,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.43B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Teacher Retirement System Of Texas Portfolio

Follow Teacher Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Teacher Retirement System Of Texas with notifications on news.